9th India Pharma 2026 conference commenced in New Delhi, focusing on innovation, self-reliance, and global leadership in pharmaceuticals.
Government announced Biopharma Shakti Initiative with ₹10,000 crore outlay and highlighted PLI schemes for domestic manufacturing enhancement.
India contributes 20% of global generic medicines and meets 70% of global vaccine demand, with biosimilars market projected at $75 billion by 2030.
Event featured discussions on AI in drug discovery, policy frameworks, and strategies to enhance India's global competitiveness in life sciences.